Article Details
Retrieved on: 2022-12-08 17:56:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 10,829,144 shares of the biopharmaceutical company's stock valued at $1,768,291,000 after purchasing an additional ...
Article found on: www.etfdailynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here